BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/12/2015 7:39:00 PM | Browse: 1104 | Download: 1579
Publication Name World Journal of Pharmacology
Manuscript ID 14199
Country/Territory United States
Received
2014-09-24 08:27
Peer-Review Started
2014-09-24 17:26
To Make the First Decision
2014-10-14 17:50
Return for Revision
2014-10-17 12:17
Revised
2014-10-22 04:27
Second Decision
2014-12-11 08:52
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-12-17 16:53
Articles in Press
2014-12-17 16:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-03-03 11:45
Publish the Manuscript Online
2015-03-12 19:39
ISSN 2220-3192 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Microbiology
Manuscript Type Review
Article Title Antimicrobial resistance in clinically important biofilms
Manuscript Source Invited Manuscript
All Author List Fatemeh Rafii and Mark E Hart
Funding Agency and Grant Number
Corresponding Author Fatemeh Rafii, Research Microbiologist, Division of Microbiology, National Center for Toxicological Research, FDA, Jefferson, AR 72079, United States. fatemeh.rafii@fda.hhs.gov
Key Words Biofilm; Bacteria; Antimicrobial agent; Medical devices; Nosocomial infections; Resistance
Core Tip Biofilm formation on host tissues and medically implanted devices is a major health problem, and the infections caused by bacteria in biofilms are hard to treat with antimicrobial agents. They are the cause of frequent and recurrent infections after the termination of antimicrobial treatments. The reasons for the recalcitrant nature of biofilms to antimicrobial treatment are varied and have been attributed to different factors, including impermeability of biofilms, slow rates of growth and metabolic activity, and the presence of small colonies and persisters. They have been the subject of many investigations that will be discussed in this minireview.
Publish Date 2015-03-12 19:39
Citation Rafii F, Hart ME. Antimicrobial resistance in clinically important biofilms. World J Pharmacol 2015; 4(1): 31-46
URL http://www.wjgnet.com/2220-3192/full/v4/i1/31.htm
DOI http://dx.doi.org/10.5497/wjp.v4.i1.31
Full Article (PDF) WJP-4-31.pdf
Full Article (Word) WJP-4-31.doc
Manuscript File 14199-Review.doc
Answering Reviewers 14199-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form 14199-Conflict-of-interest statement.pdf
Copyright License Agreement 14199-Copyright assignment.pdf
Peer-review Report 14199-Peer review(s).pdf
Scientific Misconduct Check 14199-CrossCheck.jpg
Scientific Editor Work List 14199-Scientific editor work list.pdf